News | October 17, 2014

IMRIS Horseshoe Headrest Named Life Sciences Alley New Technology Showcase Winner

Headrest provides non-pinned patient head support with Visius Surgical Theatre

October 17, 2014 — IMRIS Inc. today announced that its horseshoe headrest has been selected as one of 10 New Technology Showcase Winners by Twin Cities-based Life Sciences Alley (LSA), the nation's largest regional medical industry association. The first magnetic resonance (MR)-safe and computed tomography (CT)-compatible horseshoe headrest was introduced in February and will be among the products featured at the LSA Health Technology Leadership Conference on Nov. 19 in Minneapolis.

The horseshoe headrest provides non-pinned patient head support in prone, lateral, and supine positions during head, neck and cervical spine surgeries within the Visius Surgical Theatre, where use of a head fixation device (HFD) — a clamp-like device — is not desirable because the skull is too fragile for pinning. These patients may be babies whose skulls are still soft or older patients with weakened skull bones.

The headrest also was specially designed for use with the new IMRIS InSitu wireless coil, a sterile, wireless, ultra-lightweight and disposable imaging coil that eliminates the need to manage cables and heavy imaging coils typically draped and removed between intraoperative scans.

Inside a Visius Surgical Theatre equipped with either high-field intraoperative MRI (iMRI) or 64-slice intraoperative computed tomography (iCT), surgeons have on-demand access to real-time, diagnostic quality imaging during the procedure and from the operating room table as the scanner moves to the patient on ceiling-mounted rails. Visius iMRI provides neurosurgeons the ability to assess and decide to perform further resection for removing as much tumor as possible by clearly visualizing tumor and healthy brain tissue which otherwise are hard to differentiate.

For more information: www.lifesciencealley.com

Related Content

This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Somatom go.All and Somatom go.Top computed tomography (CT)...
Canon Medical Systems' Aquilion Precision CT Receives FDA Clearance
Technology | Computed Tomography (CT) | April 13, 2018
April 13, 2018 — Canon Medical Systems USA Inc. this week received U.S.
Volpara Solutions and Mammography Educators Launch Mammography Positioning Training Videos
News | Mammography | April 12, 2018
Volpara Solutions Inc. and mammography education provider Mammography Educators LLC announced the launch of training...
Brainomix Secures $9.8m Investment to Tackle Strokes With AI
News | Stroke | April 05, 2018
April 5, 2018 — Medical imaging company Brainomix has attracted £7m ($9.8 million) of investment to bring its...
FDA Clears Siemens Somatom Edge Plus CT System
Technology | Computed Tomography (CT) | April 04, 2018
April 4, 2018 — The U.S.
Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Computed Tomography (CT) | March 27, 2018
March 27, 2018 — Edwards Lifesciences Corp.
Overlay Init